Latest Insider Transactions at Oak Street Health, Inc. (OSH)
This section provides a real-time view of insider transactions for Oak Street Health, Inc. (OSH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Oak Street Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Oak Street Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Exercise of conversion of derivative security
|
Direct |
1,831
-0.05%
|
$38,451
$21.0 P/Share
|
|
Mar 13
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,296
+0.29%
|
-
|
|
Mar 13
2023
|
Griffin Myers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,852
+49.58%
|
-
|
|
Mar 13
2023
|
Timothy M Cook Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,458
+1.26%
|
-
|
|
Mar 13
2023
|
Michael T Pykosz Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,605
+0.35%
|
-
|
|
Mar 13
2023
|
Robert Guenthner Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,981
+2.62%
|
-
|
|
Mar 09
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,250
-1.87%
|
$288,750
$35.43 P/Share
|
|
Mar 07
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.29%
|
$1,750,000
$35.54 P/Share
|
|
Mar 07
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.28%
|
$1,050,000
$21.0 P/Share
|
|
Feb 23
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
7,728
-0.2%
|
$270,480
$35.48 P/Share
|
|
Feb 23
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,768
-1.2%
|
$376,880
$35.47 P/Share
|
|
Feb 23
2023
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,107
-0.38%
|
$178,745
$35.48 P/Share
|
|
Feb 22
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
122,985
-3.08%
|
$4,304,475
$35.61 P/Share
|
|
Feb 22
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
122,985
+2.98%
|
$2,582,685
$21.0 P/Share
|
|
Feb 21
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.27%
|
$1,750,000
$35.32 P/Share
|
|
Feb 21
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.26%
|
$1,050,000
$21.0 P/Share
|
|
Feb 10
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
7,413
-0.19%
|
$259,455
$35.6 P/Share
|
|
Feb 10
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,413
+0.19%
|
$155,673
$21.0 P/Share
|
|
Feb 09
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,250
-1.79%
|
$288,750
$35.26 P/Share
|
|
Feb 07
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
400,000
-9.36%
|
$13,600,000
$34.07 P/Share
|
|
Feb 07
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
400,000
+8.56%
|
$8,400,000
$21.0 P/Share
|
|
Feb 02
2023
|
Timothy M Cook Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,480
-0.11%
|
$41,440
$28.49 P/Share
|
|
Feb 02
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
592
-0.13%
|
$16,576
$28.85 P/Share
|
|
Jan 26
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,250
-0.88%
|
$231,000
$28.52 P/Share
|
|
Jan 13
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,809
-4.25%
|
$624,270
$30.15 P/Share
|
|
Jan 12
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
6,601
-1.33%
|
$198,030
$30.02 P/Share
|
|
Jan 11
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
32,590
-6.16%
|
$977,700
$30.11 P/Share
|
|
Jan 10
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
50,000
-1.29%
|
$1,450,000
$29.74 P/Share
|
|
Jan 10
2023
|
Geoffrey M Price Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+1.27%
|
$1,050,000
$21.0 P/Share
|
|
Jan 10
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
17,569
-1.61%
|
$509,501
$29.22 P/Share
|
|
Jan 03
2023
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.45%
|
$115,000
$23.1 P/Share
|
|
Dec 01
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.9%
|
$105,000
$21.83 P/Share
|
|
Nov 01
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.89%
|
$100,000
$20.57 P/Share
|
|
Oct 18
2022
|
Newlight Partners LP Director |
SELL
Other acquisition or disposition
|
Indirect |
120,879
-0.37%
|
-
|
|
Oct 04
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,431
-0.43%
|
$60,775
$25.3 P/Share
|
|
Oct 03
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.44%
|
$120,000
$24.42 P/Share
|
|
Sep 22
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.34%
|
$1,300,000
$26.3 P/Share
|
|
Sep 16
2022
|
Newlight Partners LP Director |
SELL
Open market or private sale
|
Indirect |
838,496
-2.5%
|
$20,123,904
$24.72 P/Share
|
|
Sep 08
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.34%
|
$1,350,000
$27.17 P/Share
|
|
Sep 06
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-1.8%
|
$1,000,000
$25.32 P/Share
|
|
Sep 01
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.43%
|
$250,000
$25.7 P/Share
|
|
Aug 25
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-1.0%
|
$1,400,000
$28.95 P/Share
|
|
Aug 23
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-1.75%
|
$1,000,000
$25.9 P/Share
|
|
Aug 19
2022
|
Newlight Partners LP Director |
SELL
Open market or private sale
|
Indirect |
7,000,000
-17.28%
|
$168,000,000
$24.72 P/Share
|
|
Aug 17
2022
|
Brian Clem Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.42%
|
$250,000
$26.0 P/Share
|
|
Aug 11
2022
|
Griffin Myers Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
50,000
-0.5%
|
$1,450,000
$29.46 P/Share
|
|
Aug 11
2022
|
Michael T Pykosz Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15
-0.0%
|
$435
$29.32 P/Share
|
|
Aug 10
2022
|
Brian Clem Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
7,700
-1.29%
|
-
|
|
Aug 09
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-3.35%
|
$1,160,000
$29.08 P/Share
|
|
Aug 08
2022
|
Geoffrey M Price Chief Innovation Officer |
SELL
Open market or private sale
|
Indirect |
100,729
-7.78%
|
$3,021,870
$30.48 P/Share
|